SCHEMBL12901010

SCHEMBL12901010

Cc1ccc(NC(=O)c2ccc(CN3CCN(CCN)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 18/20 0.89
BCR P11274 14/20 0.89
KIT P10721 11/20 0.87
PDGFRA P16234 6/20 0.87
ABL2 P42684 4/20 0.87
LYN P07948 3/20 0.87
PDGFRB P09619 2/20 0.87
SRC P12931 2/20 0.87
SYK P43405 2/20 0.87
PLK4 O00444 1/20 0.87
DDX3X O00571 1/20 0.87
GAK O14976 1/20 0.87
SLC22A2 O15244 1/20 0.87
MAPK13 O15264 1/20 0.87
CA12 O43570 1/20 0.87
SLC22A3 O75751 1/20 0.87
ABCB11 O95342 1/20 0.87
EGFR P00533 1/20 0.87
CA1 P00915 1/20 0.87
CA2 P00918 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5911492 0.95 ABL1 (0.85) ABL1BCRKITPDGFRAABL2
SCHEMBL31553098 0.95 ABL1 (0.94) ABL1BCRKITPDGFRAABL2
SCHEMBL12288611 0.94 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
SCHEMBL11939066 0.93 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
SCHEMBL12767732 0.93 ABL1 (0.89) ABL1BCRKITPDGFRAABL2
SCHEMBL4404359 0.93 ABL1 (0.89) ABL1BCRKITPDGFRAABL2
Imatinib SCHEMBL29351601 0.93 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
Imatinib SCHEMBL29355523 0.93 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
Imatinib SCHEMBL2236091 0.93 ABL1 (1.00) ABL1BCRKITPDGFRAABL2
Imatinib SCHEMBL3827 0.93 ABL1 (1.00) ABL1BCRKITPDGFRAABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9605041-B2 Regulatory proteins and inhibitors INTRA-CELLULAR THERAPIES, INC. (US) 2017-03-28 US disclosed
WO-2011016861-A2 NOVEL REGULATORY PROTEINS AND INHIBITORS INTRA-CELLULAR THERAPIES, INC. (US) 2011-02-10 WO disclosed